ALEMBICLTD2023-10-012023-12-31 ALEMBICLTD2023-10-012023-12-31 ALEMBICLTD2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member ALEMBICLTD2023-10-012023-12-31in-bse-fin:OneOperatingExpenses02Member ALEMBICLTD2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member ALEMBICLTD2023-10-012023-12-31in-bse-fin:FourOperatingExpenses02Member ALEMBICLTD2023-12-31 ALEMBICLTD2023-10-012023-12-31in-bse-fin:OneReportableSegmentRevenue01Member ALEMBICLTD2023-10-012023-12-31in-bse-fin:OneReportableSegmentRevenue02Member ALEMBICLTD2023-10-012023-12-31in-bse-fin:FourReportableSegmentRevenue01Member ALEMBICLTD2023-10-012023-12-31in-bse-fin:FourReportableSegmentRevenue02Member ALEMBICLTD2023-10-012023-12-31in-bse-fin:OneReportableSegmentResults01Member ALEMBICLTD2023-10-012023-12-31in-bse-fin:OneReportableSegmentResults02Member ALEMBICLTD2023-10-012023-12-31in-bse-fin:FourReportableSegmentResults01Member ALEMBICLTD2023-10-012023-12-31in-bse-fin:FourReportableSegmentResults02Member ALEMBICLTD2023-10-012023-12-31in-bse-fin:OneReportableSegmentAssets01Member ALEMBICLTD2023-10-012023-12-31in-bse-fin:OneReportableSegmentAssets02Member ALEMBICLTD2023-10-012023-12-31in-bse-fin:OneReportableSegmentLiabilities01Member ALEMBICLTD2023-12-31in-bse-fin:OneReportableSegmentLiabilities01Member ALEMBICLTD2023-10-012023-12-31in-bse-fin:OneReportableSegmentLiabilities02Member ALEMBICLTD2023-12-31in-bse-fin:OneReportableSegmentLiabilities02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 506235 ALEMBICLTD NOTLISTED Alembic Limited Equity 2023-04-01 2024-03-31 2024-02-14 2024-02-05 INR Lakhs Third quarter 16:00:00 16:40:00 2024-02-14 2024-02-14 Not applicable Multi segment 2023-10-01 2023-12-31 Unaudited Standalone 379402000.00 22134000.00 401536000.00 15820000.00 0.00 -3446000.00 55764000.00 2629000.00 25657000.00 179853000.00 276277000.00 125259000.00 0.00 125259000.00 -4262000.00 16630000.00 12368000.00 0.00 112891000.00 0.00 0.00 0.00 0.00 112891000.00 -142915000.00 -30024000.00 0.00 0.00 513564000.00 2 0.44 0.44 0.00 0.00 0.44 0.44 1.The above results have been reviewed by Statutory Auditors, recommended by Audit Committee and approved by the Board of Directors of the Company. 2.Exceptional item for the year ended 31st March, 2023 represents provision made by the Company towards balance of the principal amount (total principal amount being Rs. 2,052.13 lakhs) for the disputed matter(s) filed against State of Gujarat, Collector of Electricity Duty & others. The interest amount thereon is not ascertainable and is disclosed as contingent liability. Further, as communicated by the Company with the stock exchanges vide its letter dated 15th May, 2023, the Company has deposited Rs. 35 Crores with the Hon’ble Supreme Court of India on 26th May, 2023 and the appeal filed by the Company has been admitted. 3.The previous quarter's / year's figures have been regrouped / rearranged wherever necessary to make it comparable with the current quarter / year. 4.Figures rounded off to the nearest decimal Multi segment 2023-04-01 2023-12-31 Unaudited Standalone 1047401000.00 526637000.00 1574038000.00 53839000.00 0.00 15461000.00 174755000.00 3592000.00 60764000.00 474608000.00 783019000.00 791019000.00 0.00 791019000.00 57755000.00 11199000.00 68954000.00 0.00 722065000.00 0.00 0.00 0.00 0.00 722065000.00 -62497000.00 659568000.00 0.00 0.00 513564000.00 2 2.81 2.81 0.00 0.00 2.81 2.81 Cost of Construction 128894000.00 Other Expenses 50959000.00 Cost of Construction 300740000.00 Other Expenses 173868000.00 Active Pharmaceuticals Ingredients Business 64766000.00 Real Estate 314636000.00 Active Pharmaceuticals Ingredients Business 237681000.00 Real Estate 809720000.00 379402000.00 1047401000.00 0.00 0.00 379402000.00 1047401000.00 Active Pharmaceuticals Ingredients Business 10093000.00 Real Estate 110650000.00 Active Pharmaceuticals Ingredients Business 23772000.00 Real Estate 281462000.00 120743000.00 305234000.00 2629000.00 3592000.00 -7145000.00 1.The above results have been reviewed by Statutory Auditors, recommended by Audit Committee and approved by the Board of Directors of the Company. 2.Exceptional item for the year ended 31st March, 2023 represents provision made by the Company towards balance of the principal amount (total principal amount being Rs. 2,052.13 lakhs) for the disputed matter(s) filed against State of Gujarat, Collector of Electricity Duty & others. The interest amount thereon is not ascertainable and is disclosed as contingent liability. Further, as communicated by the Company with the stock exchanges vide its letter dated 15th May, 2023, the Company has deposited Rs. 35 Crores with the Hon’ble Supreme Court of India on 26th May, 2023 and the appeal filed by the Company has been admitted. 3.The previous quarter's / year's figures have been regrouped / rearranged wherever necessary to make it comparable with the current quarter / year. 4.Figures rounded off to the nearest decimal -489377000.00 125259000.00 791019000.00 Active Pharmaceuticals Ingredients Business 1830143000.00 Real Estate 3458205000.00 5288348000.00 4587417000.00 9875765000.00 Active Pharmaceuticals Ingredients Business 291528000.00 Real Estate 820473000.00 1112001000.00 379256000.00 1491257000.00 -161287000.00 -72278000.00 -18372000.00 -9781000.00 0.00 0.00